What reute do we take with Lactobacillus reuteri for antibiotic associated diarrhea? Iona Berger August 16, 2016
|
|
- Isaac Walsh
- 6 years ago
- Views:
Transcription
1 What reute do we take with Lactobacillus reuteri for antibiotic associated diarrhea? Iona Berger August 16,
2 Objectives o Describe the evidence for probiotics (e.g. lactobacillus reuteri) for treatment and prevention of antibiotic associated diarrhea in a pediatric setting o Describe the adverse events associated with probiotics (e.g. lactobacillus reuteri) use o Apply the literature presented to our patient 2
3 Meet our Patient ID KW 2 mos 16 day old, 5.3kg, female admitted on July 26 CC Irritable and fever on admission (38.9 o C) HPI Hx of fever (39.2 o C), irritable and fussy x 2 nights Birth Hx Born at wks, SVD, Mom GBS +, mom didn t receive antibiotics Birth weight: 2.58 kg Allergies NKDA 3
4 Meet our Patient Immunization None KW was sick for 2 mos vaccinations PMHx MPTA Social history Previously healthy. Had a cough ~ 2-3 weeks ago, has resolved. Vitamin D 400 units PO daily Lives with mom, dad, and two older brothers at home Exclusively breastfed Family history Family ill 3 wks ago with congestion and cough Parents are both penicillin allergic 4
5 Review of Systems Vitals Tmax: 38.9 o C, HR: 176, RR: 40-60, O 2 sat: 96-98% on RA CNS Irritable, crying HEENT CVS RESP Unremarkable Unremarkable Unremarkable GI Feeding normally, mom reports more loose stools 5
6 Review of Systems GU/renal Liver Lytes/Fluids U/O: 0.9 ml/kg/hr, urine was cloudy. Renal U/S; no congenital abnormalities found U/A (07/26): +2 leuko, +1 nitrites, +4 blood, x 10 9 WBCs Unremarkable Na+: 138, K+: 8.0 (hemolyzed), HCO 3 : 15, Cl:103 Heme WBC: 18.9, Neuts: 10.4, Hgb: 101, Platelets: 496, CRP: 55 Endocrine MSK Derm Unremarkable Unremarkable Mottled skin colour, no rash 6
7 Microbiology Date Test Result July 26 CSF differential /stain +1 mononuclear cell, no organisms, lymph 16%, monocytes 84% July 26 Blood culture E. coli (after 18 hours) July 26 Urine culture E. coli >100 megacfu/l Sensitive Meropenem Amikacin Trimethoprim Resistance Ampicillin Cefazolin Ceftriaxone Cefotaxime Gentamicin Tobramycin 7
8 Medical Problem List Medical Problems Urosepsis Medications Meropenem 110mg IV Q8H (~60mg/kg/day) x 14 days (since start of meropenem, July 28) Acetaminophen 60mg PO Q6H PRN (11.1mg/kg/dose) Bone growth Vitamin D 400 units PO daily 8
9 Ruh-oh-uro-sepsis treatment caused complications Pt sent to BCCH for PICC insertion At BCCH BioGaia (Lactobacillus reuteri) started 2 0 to mom s concerns about antibiotic associated diarrhea Pt s mom requested that L. reuteri be started upon return to SMH 9
10 Medical Problem List Medical Problems Urosepsis Medications Meropenem 110mg Q8H (~60mg/kg/day) x 14 days (since start of meropenem, July 28) Acetaminophen 60mg PO Q6H PRN (11.1mg/kg/dose) Bone growth Antibiotic-associated diarrhea Vitamin D 400 units PO daily Lactobacillus reuteri (BioGaia) ordered 10
11 DTPs KW is experiencing increasingly watery stools (? antibiotic-associated diarrhea) and would benefit from reassessment of drug therapy KW is experiencing urosepsis and requires reassessment of drug therapy KW is at risk of vaccine preventable diseases and requires her 2 month vaccinations 11
12 DTPs KW is experiencing increasingly watery stools (? antibiotic-associated diarrhea) and would benefit from reassessment of drug therapy KW is experiencing urosepsis and requires reassessment of drug therapy KW is at risk of vaccine preventable diseases and requires her 2 month vaccinations 12
13 Antibiotic associated diarrhea 3 loose stools/day for 2 days Symptoms: Mild: watery, less formed stools w/ frequency Fulminant: watery diarrhea, fever, leukocytosis Complications include toxic megacolon, perforation, and shock. Antibiotics incidence of AAD: amoxicillin, amox-clav, cephalosporins and clindamycin 13
14 Antibiotic associated diarrhea Antibiotic therapy causes imbalance in colonic microbiota Microbiota alteration changes carbohydrate metabolism with short-chain fatty acid absorption and results in osmotic diarrhea Antibiotic tx can cause overgrowth of potentially pathogenic organisms, e.g. C. difficile 14
15 Goals of Therapy 1. Prevent morbidity (=dehydration, perianal rash, fulminant diarrhea) secondary to diarrhea 2. Alleviate signs and symptoms (increased frequency of runny stools) 3. Minimize adverse drug reactions 4. Educate family on antibiotic associated diarrhea 15
16 Alternatives Rehydration if dehydrated Discontinuation of provoking agent or changing antibiotic to one with risk of inducing diarrhea (e.g. quinolones, SMX/TMP, aminoglycosides) Probiotics: e.g. Lactobacillus reuteri 16
17 Proposed mechanism of probiotics Probiotics offer protection from potential pathogens by: o Providing colonization resistance o Enhancing mucosal barrier function by secreting mucins o Increasing tight junctions o Producing bacteriocins o Producing a balanced T-helper cell response 17
18 Guidelines CPS Statement (2015) Suggest benefits in using probiotics for: Prevention of antibiotic-associated-diarrhea Treatment of acute infectious viral diarrhea AAP Statement (2010) Suggest benefit of probiotics for prevention of AAD Do not recommend treatment of AAD with probiotics 18
19 Clinical Question Patient Pediatric (age <18) with antibiotic associated diarrhea (AAD) Intervention Probiotics (e.g. Lactobacillus reuteri) for treatment of AAD Comparison Placebo Outcome Efficacy: Diarrhea (# of watery stools, consistency of stools) Safety: Adverse events, precautions or contraindications
20 Search Strategy Databases Search Terms Limitations Results Medline/PubMed, Web of Science, Google Scholar 1. [Probiotics] 2. [Lactobacillus reuteri] 3. [Antibiotic-associated diarrhea] 4. [Treatment] 5. [Infant] or [child] or [adolescent] or [pediatrics] 6. [Prevention] [1] + [3] + [4] + [5] Not [6] [2] + [3] + [4] + [5] Not [6] Excluded trials about: prevention, C. difficile, gastroenteritis, amebiasis-associated diarrhea. Limited to: pediatrics, English language, available through UBC library 2 case reports
21 Case Report #1 P I Land MH, et al Lactobacillus Sepsis Associated With Probiotic Therapy 6 wk old with CVC, developed copious nonbloody diarrhea (3 days after treatment of antibiotics) Lactobacillus rhamnosus GG administered through gastrostomy tube. O Pt s diarrhea improved On day 20 of L. rhamnosus, pt developed fever, marked leukocytosis and appeared quite ill. CVC was found to be cultured with Lactobacillus species. Follow up CVC removed and oral Lactobacillus treatment discontinued Pt exhibited clinical improvement, and continued on 6 wks of antibiotic therapy to cure infection. 21
22 Case Report #2 P I Land MH, et al Lactobacillus Sepsis Associated With Probiotic Therapy 6 year old with CVC and several concurrent bacterial infections over 2 mos treated with antibiotics, experienced intermittent diarrhea (sometimes explosive, negative for Rotavirus and C. difficile). Lactobacillus rhamnosus GG (Culturelle) O On day 44 of L. rhamnosus tx pt developed fever (40.3 o C) and irritable Blood cultures revealed Lactobacillus growth on peripheral BCx and on implanted port. Follow up IV ampicillin to treat Lactobacillus infection and L. rhamnosus was discontinued 22
23 Conclusion Use caution with Lactobacillus rhamnosus GG in pediatric patients with CVC lines for the treatment of antibiotic associated diarrhea. 23
24 Limitations Evidence Quality Case reports are not high level evidence. Generalizability Both case reports had CVC lines Both were already hospitalized for many weeks prior to the AAD, representing a more clinically unwell patient population. Were on a different probiotic (L. rhamnosus) Both cases had complex past medical history (=cerebral palsy, congenital heart defects) 24
25 So is that it for L. reuteri? 25
26 Preventing AAD by ADDing Probiotics? How about the efficacy of L. reuteri for prevention of antibiotic associated diarrhea? 26
27 Georgieva et al Use Of The Probiotic Lactobacillus Reuteri DSM In The Prevention Of Antibiotic- Associated Infections In Hospitalized Bulgarian Children: A Randomized, Controlled Trial. P Children aged 3-12 years, n=100 admitted for acute infections Randomized, double-blind, placebo-controlled trial. Probiotic or placebo taken 2 hours after lunch daily, during entire duration of antibiotic therapy + additional 7 days. I Probiotic with 10 8 CFU Lactobacillus reuteri DSM (1 chewable tablet once daily) C Placebo O 1) Incidence of diarrhea during and up to 21 days post-antibiotic treatment 2) Incidence of mild diarrhea during and up to 21 days postantibiotics, severity of diarrhea, frequency of stool samples positive for C. difficile toxin, frequency of other GI symptoms 27
28 Results Outcome Placebo (n=48) L. reuteri (n=49) RR (95% CI) Primary outcome: Incidence of diarrhea during and up to 21 days post-antibiotic treatment 1 (2.04%) 1 (2.1%) 0.98 ( ) Secondary outcomes Mild diarrhea incidence (# episodes) 2 (4.08%) 3 (6.3%) 1.5 ( ) Mild diarrhea severity (# of stools) 8 17 Samples positive for C. difficile toxin 15 (31.3%) 13 (28.6%) 28
29 Limitations Allocation bias Low risk as pts randomized using a computer generated randomization program Placebo arm received identical chewable tablets to L. reuteri chew tabs Baseline characteristics NSS between two arms Performance and detection bias Low risk: double blinded study Attrition bias Minimal concern: <3% dropout rate Reporting bias Minimal frequency of diarrhea between both groups (inconsistent with literature which estimates 11-30% frequency of AAD) Lack of analysis of fecal L reuteri DSM levels Generalizability Aged: 3-12 years old 29
30 Conclusions No conclusion on efficacy of L. reuteri DSM on AAD in hospitalized Bulgarian children due to low incidence of AAD in study. No difference between groups regarding different gastrointestinal side effects. 30
31 Safety evidence for probiotics Safety concerns in the literature found for: S. boulardii à S. cervasiae fungemia Especially in immunocompromised or critically ill patients L. rhamnosus and L. casei à bacteremia and endocarditis Especially in immunocompromised or pts with CVC Endocarditis was noted in pts with recent dental manipulations or dental disease 31
32 Conclusion of the evidence (L. reuteri) Efficacy No evidence of L. reuteri (or other probiotics) in treatment of antibiotic associated diarrhea No conclusive evidence of L. reuteri in prevention of antibiotic associated diarrhea Safety Caution should be exercised when using L. rhamnosus (and other probiotics) in pediatric patients with CVC lines or immunocompromised patients 32
33 Relating it to KW Recommendations: Recommend to medical team to discontinue L. reuteri to KW Educate family about risks and unknown benefit of using probiotics in treatment of antibiotic-associated diarrhea 33
34 Monitoring Plan Expected change Frequency of monitoring Fever (>38.3 o C) Afebrile Daily No signs of dehydration (= sunken eyes and fontanelle, decreased feeding, decreased U/O, dry mucous membranes) Absence Daily Diarrhea (= # of stools/day, consistency of stools) Absence Daily 34
35 Follow up Pt s mom and medical team accepted pharmacy s recommendations to discontinue L. reuteri (BioGaia). Pt s stools did not increase in frequency or liquidity, and mom did not have new concerns about diarrhea. Pt successfully finished her antibiotic therapy! Pt received 2 month vaccinations at discharge 35
36 References 1. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ [Internet]. 2002;324(7350): Available from: 2. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus Sepsis Associated With Probiotic Therapy. Pediatrics. 1976;115(1): Georgieva M, Pancheva R, Rasheva N, Usheva N, Ivanova L, Koleva K. Use Of The Probiotic Lactobacillus Reuteri DSM17938 In The Prevention Of Antibiotic-Associated Infections in Hospitalized Bulgarian Children: A Randomized, Controlled Trial. J IMAB - Annu Proceeding (Scientific Pap [Internet]. 2015;21(4): Available from: 4. Marchand V. Using probiotics in the paediatric population. Paediatric Child Health [Internet]. 2AD;17(10): Available from: 5. Thomas DW, Greer FR, American Academy of Pediatrics Committee on N, American Academy of Pediatrics Section on Gastroenterology H, Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics [Internet]. 2010;126(6): Available from: 6. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JMT. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect [Internet]. 1999;5(5): Available from: 7. Enache-Angoulvant A, Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis [Internet]. 2005;41(11): Available from: 8. Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis [Internet]. 1997;25(5): Available from: 36
37 Thank you!
38 Acknowledgement Sandy Mok and the whole CYS team J 38
39 Questions? 39
Fever Without a Source Age: 0-28 Day Pathway - Emergency Department Evidence Based Outcome Center
Age: 0-28 Day Pathway - Emergency Department EXCLUSION CRITERIA Toxic appearing No fever Born < 37 weeks gestational age INCLUSION CRITERIA Non-toxic with temperature > 38 C (100.4 F) < 36 C (96.5 F) measured
More informationProbiotics for Primary Prevention of Clostridium difficile Infection
Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss
More informationCLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System
CLOSTRIDIUM DIFICILE Negin N Blattman Infectious Diseases Phoenix VA Healthcare System ANTIBIOTIC ASSOCIATED DIARRHEA 1978: C diff first identified 1989-1992: Four large outbreaks in the US caused by J
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II
MHD II, Session 11, Student Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II Session 11 April 11, 2016 STUDENT COPY MHD II, Session 11, Student Copy Page 2 CASE HISTORY 1 Chief complaint: Our baby
More informationA Randomized Open Label Comparative Clinical Study of a Probiotic against a Symbiotic in the Treatment of Acute Diarrhoea in Children
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(9): 96-100 I J M R
More informationClostridium difficile Infection (CDI) Management Guideline
Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for
More informationPthaigastro.org. Drugs Used in Acute Diarrhea: Cons. Nipat Simakachorn, M.D. Department of Pediatrics Maharat Nakhon Ratchasima Hospital.
Drugs Used in Acute Diarrhea: Cons Nipat Simakachorn, M.D. Department of Pediatrics Maharat Nakhon Ratchasima Hospital 27-Apr-2012 Optimistic Pessimistic Global percentage of children
More informationACUTE GASTROENTERITIS IN CHILDREN
ACUTE GASTROENTERITIS IN CHILDREN Prof. Alok Kumar Professor of Pediatrics & Infectious Diseases Faculty of Medical Sciences The University of the West Indies (Cave Hill) 11/6/2017 1 DEFINITION Gastroenteritis
More informationAn Intriguing Case of Meningitis. Tiffany Mylius MLS (ASCP)
An Intriguing Case of Meningitis { Tiffany Mylius MLS (ASCP) A 4yo male presents with 2wk history of URI symptoms. On the day of admission, the patient woke up with a HA in the morning, took a nap later
More informationUTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys.
UTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys. 1-3% of Below 1 yr. male: female ratio is 4:1 especially among uncircumcised males,
More informationClinical Report: Probiotics and Prebiotics in Pediatrics
www.medscape.com Authors and Disclosures Author(s) Dan W. Thomas, MD Professor of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California; Head, Division of Gastroenterology
More informationHot Hot Tot:! The Hot Tot. Fever in KIds <90 Days 5/26/10
Hot Hot Tot:! Fever in KIds
More informationProbiotics in Pediatric Health. AANP Annual Convention
Probiotics in Pediatric Health AANP Annual Convention Don Brown, ND July 12, 2017 Human Microbiome Richness and Metabolic Markers Human gut microbial composition was studied in 292 Danish adults Individuals
More informationAcute Gastroenteritis
Acute Gastroenteritis Definitions Epidemiology Clinical presentation Diagnostics Therapy Erdélyi, Dániel 2018.04.10. Definitions Acute gastroenteritis (AGE): Loose or liquid stools 3 times daily (better:
More informationUpdate on Probiotic Use in Children with Diarrhoea
Update on Probiotic Use in Children with Diarrhoea Ahmed Laving Paediatric Gastroenterologist and Senior Lecturer, University of Nairobi KPA Annual Scientific Meeting, Kisumu 2017 Outline Physiology of
More informationProbiotics: Their Role in Medicine Today. Objectives. Probiotics: What Are They? 11/3/2017
Probiotics: Their Role in Medicine Today Viki Barr Pharm.D., BCPS AQ ID Assistant Professor, Pharmacy Practice Rosalind Franklin University of Medicine and Science Clinical Pharmacist, Infectious Diseases
More informationFevers and Seizures in Infants and Young Children
Fevers and Seizures in Infants and Young Children Kellie Holtmeier, PharmD Pediatric Clinical Pharmacist University of New Mexico Hospital Disclosure I have no conflicts of interest 1 Pharmacist Objectives
More informationENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE
ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual
More informationDISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit
GASTROENTERITIS DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest within this presentation fidaxomicin (which
More informationUpdated Clostridium difficile Treatment Guidelines
Updated Clostridium difficile Treatment Guidelines Arielle Arnold, PharmD, BCPS Clinical Pharmacist Saint Alphonsus Regional Medical Center September 29 th, 2018 Disclosures Nothing to disclose Learning
More informationהשפעת חיידקים פרוביוטיים
השפעת חיידקים פרוביוטיים החיים בחלל )המעי(... על רון שאול יחידת גסטרו ילדים מרכז רפואי רמב"ם Introduction The intestinal microflora primarily in the large bowel consists mostly on benign bacterial species
More informationROLE OF THE GUT BACTERIA
ROLE OF THE GUT BACTERIA Our Good Bacteria In a perfect world, we would all have a proper ratio of good bacteria And what could this proper ratio do for us? The knowledge of the connections between our
More informationEDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE
EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click
More informationPEDIATRIC INFECTIOUS DISEASES UPDATE. Neonatal HSV. Recognition, Diagnosis, and Management Coleen Cunningham MD
Neonatal HSV Recognition, Diagnosis, and Management Coleen Cunningham MD Important questions Who is at risk? When do you test? What tests do you perform? When do you treat? What is appropriate therapy?
More informationGrande half-sweet caffeine for post-dural headaches. Iona Berger January 31, 2017
Grande half-sweet caffeine for post-dural headaches Iona Berger January 31, 2017 1 Objectives o Describe the pathophysiology and signs and symptoms of post-dural headaches o Explain the proposed mechanism
More information1. Introduction Algorithm: Infant with Fever 0-28 Days Algorithm: Infant with Fever Days...3
These guidelines are designed to assist clinicians and are not intended to supplant good clinical judgement or to establish a protocol for all patients with this condition. MANAGEMENT OF FEVER 38 C (100.4F)
More informationThe McMaster at night Pediatric Curriculum
The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives
More informationClinical Assessment Tool
Clinical Assessment Tool Child with Suspected Gastroenteritis 0-5 Years Diarrhoea is defined as the passage of three or more loose/watery stools per day, the most common cause of diarrhoea in children
More informationFever Phobia and the ED Doc Ran Goldman, MD (rgoldman@cw.bc.ca) BC Children s Hospital, Professor, University of British Columbia SLIDES ON : www.clinicalpeds.com/whistler Define Fever 38.0 o Doesn t
More information9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)
Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In
More informationGood Morning! Welcome Applicants! FRIDAY, N OVEMBER, 7 TH 2014
Good Morning! Welcome Applicants! FRIDAY, N OVEMBER, 7 TH 2014 Prep Question You are camping with a group of boys at a rural campground in the southeastern Unites States when one of the campers is bitten
More informationStony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics
Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection
More informationProbiotics for children receiving antibiotics
Probiotics for children receiving antibiotics Main editor Reed Siemieniuk Publishing Info v1.1 published on 25.07.2016 WikiRecs group 1 of 12 for children receiving antibiotics Contact Language en Start
More informationFever in the Newborn Period
Fever in the Newborn Period 1. Definitions 1 2. Overview 1 3. History and Physical Examination 2 4. Fever in Infants Less than 3 Months Old 2 a. Table 1: Rochester criteria for low risk infants 3 5. Fever
More informationPrevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics
Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics DGMIM, 15.-16.10.2010 16.10.2010 Stuttgart Prof. Rémy Meier, MD GI-Department University Hospital Liestal, Switzerland
More informationPaediatric Directorate
Paediatric Directorate Dehydration Guidelines Primary cause of dehydration diarrhoea +/- vomiting. Approximately 10%Children < 5yrs present with gastroenteritis each year Diagnosis History - sudden change
More information+ Objectives. n Define who is at risk for SBI. n Clarify risk stratification. n Provide treatment guidelines. n Bust some myths
Objectives n Define wo is at risk for SBI n Clarify risk stratification n Provide treatment guidelines Neonatal Fever Benjamin B. Constance, MD, FAWM n Bust some myts Based on Case wat do you want to know?
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationStudy on Incidence of Antibiotic Associated Diarrhoea in General Paediatric Ward
HK J Paediatr (new series) 2002;7:33-38 Study on Incidence of Antibiotic Associated Diarrhoea in General Paediatric Ward CM HUI, K TSE Abstract Objective: To estimate the incidence rate and risk factors
More informationESPEN Congress Vienna Networking with your microbiota Specific evidence-based indications. H. Lochs (Germany)
ESPEN Congress Vienna 2009 Networking with your microbiota Specific evidence-based indications H. Lochs (Germany) Probiotics Evidence based indications H. Lochs Medizinische Klinik mit Schwerpunkt Gastroenterologie,
More informationThe McMaster at night Pediatric Curriculum
The McMaster at night Pediatric Curriculum Robinson, J, et al. and the Canadian Pediatric Society. Urinary tract infection in infants and children: Diagnosis and management. Pediatr Child Health 2014;
More informationImmodium / loprarmide
Immodium / loprarmide IMODIUM (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease.
More informationWhat Are Probiotics? PROBIOTICS
PROBIOTICS What Are Probiotics? Probiotics are living, microscopic (very small) organisms that can help your gut health. Most often, probiotics are bacteria, but they may also be other organisms, such
More informationAntibiotic Protocols for Paediatrics Steve Biko Academic Hospital
Antibiotic Protocols for Paediatrics Steve Biko Academic Hospital Respiratory tract infections in children Uncomplicated URTI A child with a cold should not receive an antibiotic Paracetamol (15 mg/kg/dose
More information11/9/2012. Group B Streptococcal Infections: Consensus and Controversies. Prevention of Early-Onset GBS Disease in the USA.
Group B Streptococcal Infections: Consensus and Controversies Carol J. Baker, M.D. Professor of Pediatrics, Molecular Virology and Microbiology Executive Director, Center for Vaccine Awareness and Research
More informationEvidence-based Management of Fever in Infants and Young Children
Evidence-based Management of Fever in Infants and Young Children Shabnam Jain, MD, MPH Associate Professor of Pediatrics Emory University Medical Director for Clinical Effectiveness Objectives Understand
More informationThe Potential For Microbiome Modification In Critical Illness. Deborah Cook
The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to
More informationUnderstanding probiotics and health
Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,
More informationPEDIATRIC CYSTIC FIBROSIS PLAN - Phase:.
PHYSICIAN S Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards Per Unit Standards, with Sleeping SpO2 nightly until sat greater than 92% Daily Weight Every AM In AM on Monday, Wednesday,
More informationmore intense treatments are needed to get rid of the infection.
What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium that can grow in your intestines and cause bad GI symptoms. The main risk of getting
More informationIDPH ESF-8 Plan: Pediatric and Neonatal Surge Annex Sample Pediatric Admission Orders 2015
Purpose: To provide guidance to practitioners caring for pediatric patients who need inpatient hospital care during a disaster. Disclaimer: This guideline is not meant to be all inclusive, replace an existing
More informationDisclosures. Background. Definitions. Why Worry about these Infants? Goals. Bacterial infection in the neonate and young infant: a review
Disclosures Bacterial infection in the neonate and young infant: a review Russell J. McCulloh, MD Med-Peds Infectious Diseases August 8, 2017 I have no financial interests to disclose Funding: Eva and
More informationUpdates to pharmacological management in the prevention of recurrent Clostridium difficile
Updates to pharmacological management in the prevention of recurrent Clostridium difficile Julia Shlensky, PharmD PGY2 Internal Medicine Resident September 12, 2017 2017 MFMER slide-1 Clinical Impact Increasing
More informationHomeopathic Products. Evidence??
Homeopathic Products Principle of analogy or Law of Similars Small or infinitesimal doses (3X-30C) Avogadro s number=6x10 23 = ~23X Succussion and potentization (see http://www.boiron.com/en/htm/02_medi_hom
More informationClostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018
Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018 Disclosures None Objectives Highlight important changes in the management of Clostridium difficile
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More informationClostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate
Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium
More informationChristina Tennyson, M.D. Division of Gastroenterology
Diarrhea Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University DIARRHEA Symptom: stool frequency, liquidity Sign: > 200-250 g/day Acute Chronic Time
More information2/26/2009. Diarrhea. Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University
Diarrhea Christina Tennyson, M.D. Assistant Professor of Medicine Division of Gastroenterology Columbia University 1 Symptom: Sign: DIARRHEA stool frequency, liquidity > 200-250 g/day Acute Chronic Time
More informationPediatric Case Studies. Case 1
Pediatric Case Studies James Naprawa, MD Assistant Clinical Professor Pediatric Emergency Medicine Children s Hospital, Columbus Case 1 Almost 4 year old AA girl PMH UTI x 2 with abdominal pain and fever
More informationDoes Bicarbonate Concentration Predict Hospitalization among Children with Gastroenteritis?
Does Bicarbonate Concentration Predict Hospitalization among Children with Gastroenteritis? Muin Habashneh MD*, Mohammad Alrwalah MD* ABSTRACT Objective: To determine the relationship between bicarbonate
More informationEED INTERVENTIONS 3.0
EED INTERVENTIONS 3.0 Produced by: Kidane, L.; Osterman, A.; Babigumira, J. Agenda Agenda Project Background and Objectives Approach & Rationale Methods Results Discussion and Next Steps 2 Project Background
More informationProbiotiques et infections, Un sujet «incertain»
Probiotiques et infections, Un sujet «incertain» antoine.andremont@bch.aphp.fr 1 2 General : So, a strict roadmad. Definition, Market Recent findings in : Infectious diarrhea, C. dif, VRE, UTI, VAP, Pediatrics,
More informationMODULE VI. Diarrhea and Dehydration
MODULE VI Diarrhea and Dehydration ACUTE DIARRHEA Increased number of bowel movements! Loose and watery stools Fluid and electrolyte loss ACUTE DIARRHEA TYPES Watery Bloody diarrhea (dysentery) DIARRHEA
More informationOsteomyelitis Samir S. Shah, MD, MSCE
Osteomyelitis Samir S. Shah, MD, MSCE Professor, Department of Pediatrics University of Cincinnati College of Medicine Director, Division of Hospital Medicine Attending Physician in Infectious Diseases
More information4/14/2010. Theoretical purpose of fever? Andrea Marmor, MD, MSEd Assistant Clinical Professor, Pediatrics UCSF April 13, 2010
Andrea Marmor, MD, MSEd Assistant Clinical Professor, Pediatrics UCSF April 13, 2010 Parental touch? Absence of fever more reliable than presence. Axillary and tympanic Vulnerable to environmental and
More information2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal
PROBIOTICS LEARNING THE WHY AND WHEN PROBIOTICS DEFINITION live micro-organisms organisms that are beneficial to the host organism WHO: Live organisms which, when administered in adequate amounts, confer
More informationUSAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp)
Improvement objective: : decrease morbidity and mortality due to acute upper (rhinitis, sinusitis, pharyngitis) and lower (bronchitis, pneumonia) respiratory infections through improved case management
More informationThe Febrile Infant. SJRH ED Rounds Dec By: Robin Clouston
1 The Febrile Infant SJRH ED Rounds Dec 11 2018 By: Robin Clouston 2 Objectives Discuss the risk of serious bacterial infection (SBI) in the neonate or young infant (
More informationManagement of Diarrhea in Critical Ill Patients CCSSA Congress Sun City 20. October 2017
Management of Diarrhea in Critical Ill Patients CCSSA Congress Sun City 20. October 2017 Prof. em Rémy Meier MD University of Basel Gastro-Center Obach Solothurn, Switzerland Outline Definition of diarrhea
More informationClostridium difficile Infection: Diagnosis and Management
Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,
More informationClostridium difficile
Clostridium difficile Alex Aspinall MD, PhD, FRCPC Clinical Assistant Professor, University of Calgary Division of Gastroenterology and Hepatology, South Health Campus www.seacourses.com 1 Learning Points
More informationDecember 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide
Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,
More informationAcute Gastroenteritis, Adult Emergency Orders
Form Title Form Number 21003 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not
More informationDr. Dafalla Ahmed Babiker Jazan University
Dr. Dafalla Ahmed Babiker Jazan University objectives Overview Definition of dehydration Causes of dehydration Types of dehydration Diagnosis, signs and symptoms Management of dehydration Complications
More informationWhen can infants and children benefit from probiotics?
When can infants and children benefit from probiotics? The latest studies indicate that probiotics can help with colic, eczema, and certain types of diarrhea. They may also help with upper respiratory
More informationPediatric urinary tract infection. Dr. Nariman Fahmi Pediatrics/2013
Pediatric urinary tract infection Dr. Nariman Fahmi Pediatrics/2013 objectives EPIDEMIOLOGY CAUSATIVE PATHOGENS PATHOGENESIS CATEGORIES OF URINARY TRACT INFECTIONS AND CLINICAL MANIFESTATIONS IN pediatrics
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationFonterra Probiotics: From guts to glory
Fonterra Probiotics: From guts to glory James Dekker April 16, 2015 Host Institution Probiotic bacteria Live micro-organisms which, when administered in adequate amounts, confer a health benefit on the
More informationClostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure
Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma
More informationFaculty Disclosure. Stephen I. Pelton, MD. Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Stephen I. Pelton, MD Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest. Advances in the management of fever in infants 0 to 3 and
More informationDiagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review
Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Juul FE, Garborg K, Bretthauer M, et al. Fecal microbiota transplantation
More informationJMSCR Vol 05 Issue 11 Page November 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i11.186 Role of Saccharomyces Boulardii and
More informationEvelyn A. Kluka, MD FAAP November 30, 2011
Evelyn A. Kluka, MD FAAP November 30, 2011 > 80% of children will suffer from at least one episode of AOM by 3 years of age 40% will have > 6 recurrences by age 7 years Most common diagnosis for which
More informationEvelina London Children s Hospital (ELCH)
Evelina London Children s Hospital (ELCH) Lead Consultant Jenny Handforth PID Pharmacist Faye Chappell Paediatric OPAT CNS Vacant Overview Paediatric OPAT in London Paediatric OPAT ELCH Children s Hospital
More informationClinical Infectious Diseases Advance Access published December 7, 2012
Clinical Infectious Diseases Advance Access published December 7, 2012 1 Physician Attitudes Towards the Use of Fecal Transplantation for Recurrent Clostridium Difficile Infection in a Large Metropolitan
More informationClostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011
Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast
More informationPhysician Orders PEDIATRIC: LEB Oral Maxillofacial Post Op Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: LEB Oral Maxillofacial Postop Phase, When to Initiate: LEB Oral Maxillofacial Post Op Phase Admission/Transfer/Discharge
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationGut bugs and health. Patrick Bateson
Gut bugs and health Patrick Bateson Characteristic odour of kin group is produced by inherited bacterial flora degrading fats secreted by anal glands An increasing number of people in developed countries
More informationGUIDELINE FOR THE MANAGEMENT OF MENINGITIS. All children with suspected or confirmed meningitis
GUIDELINE FOR THE MANAGEMENT OF MENINGITIS Reference: Mennigitis Version No: 1 Applicable to All children with suspected or confirmed meningitis Classification of document: Area for Circulation: Author:
More informationLabeled Uses: Treatment of Clostiridum Difficile associated diarrhea (CDAD)
Brand Name: Dificid Generic Name: fidaxomicin Manufacturer 1,2,3,4,5 : Optimer Pharmaceuticals, Inc. Drug Class 1,2,3,4,5 : Macrolide Antibiotic Uses 1,2,3,4,5 : Labeled Uses: Treatment of Clostiridum
More informationFever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital
Fever National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Case 1 4-month-old well-appearing girl admitted for croup and respiratory distress.
More informationFIS 2013, Birmingham
Fidaxomicin: CDDFT Case Studies Dr Deepa Nayar County Durham and Darlington Foundation Trust FIS 2013, Birmingham This meeting has been initiated and funded by Astellas Pharma Ltd. County Durham and Darlington
More informationHot Stuff: The Febrile Child
Hot Stuff: The Febrile Child Dr. Shannon MacPhee, Department of Emergency Medicine, Division Head Pediatric Emergency Medicine. IWK Health Centre. Dalhousie University November 2017 Know when to suspect
More informationDuodenal infusion of donor feces for recurrent Clostridium difficile infection A French experience
Duodenal infusion of donor feces for recurrent Clostridium difficile infection A French experience Benoit Guery Unité des Maladies Infectieuses CHRU - Faculté de Médecine Lille Conflicts of interest Conferences,
More informationDr Warren Hyer Consultant Paediatric Gastroenterologist
Dr Warren Hyer Consultant Paediatric Gastroenterologist Probiotics a cure for all? No conflict of interest to declare Aims To change your opinion of probiotic use in children To base your decision on high
More informationCase 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?
Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More information